These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38709254)
1. Prevention of Vascular Access Device-Associated Hospital Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects. Garcia R; Septimus EJ; LeDonne J; Sturm LK; Moureau N; DeVries M; DeBaun B Clin Infect Dis; 2024 May; ():. PubMed ID: 38709254 [TBL] [Abstract][Full Text] [Related]
2. Hospital epidemiologists' and infection preventionists' opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. Dantes RB; Abbo LM; Anderson D; Hall L; Han JH; Harris AD; Leekha S; Milstone AM; Morgan DJ; Safdar N; Schweizer ML; Sengupta S; Seo SK; Rock C Infect Control Hosp Epidemiol; 2019 May; 40(5):536-540. PubMed ID: 30932802 [TBL] [Abstract][Full Text] [Related]
3. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals. Yu KC; Jung M; Ai C Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226 [TBL] [Abstract][Full Text] [Related]
4. Hospital-onset bacteremia and fungemia: examining healthcare-associated infections prevention through a wider lens. Schrank GM; Snyder GM; Leekha S Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e198. PubMed ID: 38028924 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and preventability of hospital-onset bacteremia and fungemia in 2 hospitals in India. Gandra S; Singh SK; Chakravarthy M; Moni M; Dhekane P; Mohamed Z; Shameen F; Vasudevan AK; Senthil P; Saravanan T; George A; Sinclair D; Stwalley D; van Rheenen J; Westercamp M; Smith RM; Leekha S; Warren DK Infect Control Hosp Epidemiol; 2024 Feb; 45(2):157-166. PubMed ID: 37593953 [TBL] [Abstract][Full Text] [Related]
6. Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals. Yu KC; Ye G; Edwards JR; Gupta V; Benin AL; Ai C; Dantes R Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1317-1325. PubMed ID: 36082774 [TBL] [Abstract][Full Text] [Related]
7. Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure. Dantes RB; Rock C; Milstone AM; Jacob JT; Chernetsky-Tejedor S; Harris AD; Leekha S Infect Control Hosp Epidemiol; 2019 Mar; 40(3):358-361. PubMed ID: 30773166 [TBL] [Abstract][Full Text] [Related]
8. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Hospital-Onset Bacteremia Pre- and Post-Implementation of a Needleless Blood Sampling Device From Existing Peripheral Catheters. Yu KC; Ai C; Jung M; Johnson H; Smith S; LaJoie J; Denny G J Infus Nurs; 2023 Nov-Dec 01; 46(6):332-337. PubMed ID: 37490579 [TBL] [Abstract][Full Text] [Related]
11. Foundation for implementing a comprehensive vascular access excellence initiative organization-wide to improve vascular access device insertion and standardize care: best practice for an acute care hospital. Campos C; Lopez M; Irwin-Nieto V; Richards R; Deen MR; Lalata A Br J Nurs; 2023 Oct; 32(19):S26-S37. PubMed ID: 37883312 [TBL] [Abstract][Full Text] [Related]
12. Quantitative Results of a National Intervention to Prevent Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Pre-Post Observational Study. Calfee DP; Davila S; Chopra V; Patel PK; Snyder A; Ratz D; Rolle AJ; Olmsted RN; Popovich KJ Ann Intern Med; 2019 Oct; 171(7_Suppl):S66-S72. PubMed ID: 31569232 [TBL] [Abstract][Full Text] [Related]
13. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Shorr AF; Tabak YP; Killian AD; Gupta V; Liu LZ; Kollef MH Crit Care Med; 2006 Oct; 34(10):2588-95. PubMed ID: 16915117 [TBL] [Abstract][Full Text] [Related]
14. Update: Catheter-related bloodstream infection rates in relation to clinical practice and needleless device type. Blake M Can J Infect Control; 2008; 23(3):156-60, 162. PubMed ID: 19024809 [TBL] [Abstract][Full Text] [Related]
15. Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report. Patel PR; Yi SH; Booth S; Bren V; Downham G; Hess S; Kelley K; Lincoln M; Morrissette K; Lindberg C; Jernigan JA; Kallen AJ Am J Kidney Dis; 2013 Aug; 62(2):322-30. PubMed ID: 23676763 [TBL] [Abstract][Full Text] [Related]
16. Preventing bloodstream infection in IV therapy. Hugill K Br J Nurs; 2017 Jul; 26(14):S4-S10. PubMed ID: 28745951 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of new anti-infective drugs for the treatment of vascular access device-associated bacteremia and fungemia. The European Working Party of the European Society of Clinical Microbiology and Infectious Diseases. Franson TR; Zak O; van den Broek P Clin Infect Dis; 1993 Oct; 17(4):789-93. PubMed ID: 8268367 [TBL] [Abstract][Full Text] [Related]
18. Moving Beyond Central Line-Associated Bloodstream Infections: Enhancement of the Prevention Process. Garcia R J Infus Nurs; 2023 Jul-Aug 01; 46(4):217-222. PubMed ID: 37406336 [TBL] [Abstract][Full Text] [Related]
19. Minimising central line-associated bloodstream infection rate in inserting central venous catheters in the adult intensive care units. Hina HR; McDowell JRS J Clin Nurs; 2017 Dec; 26(23-24):3962-3973. PubMed ID: 28334482 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients. Patel PR; Kallen AJ; Arduino MJ Am J Kidney Dis; 2010 Sep; 56(3):566-77. PubMed ID: 20554361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]